These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8042222)

  • 1. Effects of total hemoglobin and hemoglobin S concentration on cerebral blood flow during transfusion therapy to prevent stroke in sickle cell disease.
    Hurlet-Jensen AM; Prohovnik I; Pavlakis SG; Piomelli S
    Stroke; 1994 Aug; 25(8):1688-92. PubMed ID: 8042222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.
    Adams RJ; McKie VC; Hsu L; Files B; Vichinsky E; Pegelow C; Abboud M; Gallagher D; Kutlar A; Nichols FT; Bonds DR; Brambilla D
    N Engl J Med; 1998 Jul; 339(1):5-11. PubMed ID: 9647873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.
    Mirre E; Brousse V; Berteloot L; Lambot-Juhan K; Verlhac S; Boulat C; Dumont MD; Lenoir G; de Montalembert M
    Eur J Haematol; 2010 Mar; 84(3):259-65. PubMed ID: 19912310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modified transfusion program for prevention of stroke in sickle cell disease.
    Cohen AR; Martin MB; Silber JH; Kim HC; Ohene-Frempong K; Schwartz E
    Blood; 1992 Apr; 79(7):1657-61. PubMed ID: 1558963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke prevention trial in sickle cell anemia.
    Adams RJ; McKie VC; Brambilla D; Carl E; Gallagher D; Nichols FT; Roach S; Abboud M; Berman B; Driscoll C; Files B; Hsu L; Hurlet A; Miller S; Olivieri N; Pegelow C; Scher C; Vichinsky E; Wang W; Woods G; Kutlar A; Wright E; Hagner S; Tighe F; Waclawiw MA
    Control Clin Trials; 1998 Feb; 19(1):110-29. PubMed ID: 9492971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable degrees of suppression of hemoglobin S synthesis in subjects with hemoglobin SS disease on a long-term transfusion regimen.
    Zinkham WH; Seidler AJ; Kickler TS
    J Pediatr; 1994 Feb; 124(2):215-9. PubMed ID: 8301425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral hyperemia, stroke, and transfusion in sickle cell disease.
    Prohovnik I; Pavlakis SG; Piomelli S; Bello J; Mohr JP; Hilal S; De Vivo DC
    Neurology; 1989 Mar; 39(3):344-8. PubMed ID: 2927641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Less intensive long-term transfusion therapy for sickle cell anemia and cerebrovascular accident.
    Miller ST; Jensen D; Rao SP
    J Pediatr; 1992 Jan; 120(1):54-7. PubMed ID: 1731025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease.
    Wang WC; Kovnar EH; Tonkin IL; Mulhern RK; Langston JW; Day SW; Schell MJ; Wilimas JA
    J Pediatr; 1991 Mar; 118(3):377-82. PubMed ID: 1999776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected hemoglobin electrophoresis results following red cell exchange in a sickle cell anemia patient with acute chest syndrome.
    Robertson PB; Danielson CF; McCarthy LJ
    Transfus Sci; 1997 Jun; 18(2):195-8. PubMed ID: 10174684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenectomy to Optimize Hemoglobin S Control in Children With Sickle Cell Anemia on Chronic Transfusion Therapy for Stroke Prevention.
    Black LV; Ramesar JS; Boston CH
    J Pediatr Hematol Oncol; 2019 Mar; 41(2):158-160. PubMed ID: 29668544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group.
    Vichinsky EP; Haberkern CM; Neumayr L; Earles AN; Black D; Koshy M; Pegelow C; Abboud M; Ohene-Frempong K; Iyer RV
    N Engl J Med; 1995 Jul; 333(4):206-13. PubMed ID: 7791837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting changes in hemoglobin S after simple transfusion using complete blood counts.
    Mathur G; Ten Eyck P; Knudson CM
    Transfusion; 2018 Jan; 58(1):138-144. PubMed ID: 29023896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High mortality among children with sickle cell anemia and overt stroke who discontinue blood transfusion after transition to an adult program.
    McLaughlin JF; Ballas SK
    Transfusion; 2016 May; 56(5):1014-21. PubMed ID: 26593779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic transfusion practice for children with sickle cell anaemia and stroke.
    Aygun B; McMurray MA; Schultz WH; Kwiatkowski JL; Hilliard L; Alvarez O; Heeney M; Kalinyak K; Lee MT; Miller S; Helms RW; Ware RE;
    Br J Haematol; 2009 May; 145(4):524-8. PubMed ID: 19344396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
    DeBaun MR; Gordon M; McKinstry RC; Noetzel MJ; White DA; Sarnaik SA; Meier ER; Howard TH; Majumdar S; Inusa BP; Telfer PT; Kirby-Allen M; McCavit TL; Kamdem A; Airewele G; Woods GM; Berman B; Panepinto JA; Fuh BR; Kwiatkowski JL; King AA; Fixler JM; Rhodes MM; Thompson AA; Heiny ME; Redding-Lallinger RC; Kirkham FJ; Dixon N; Gonzalez CE; Kalinyak KA; Quinn CT; Strouse JJ; Miller JP; Lehmann H; Kraut MA; Ball WS; Hirtz D; Casella JF
    N Engl J Med; 2014 Aug; 371(8):699-710. PubMed ID: 25140956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Middle cerebral artery velocity changes during transfusion in sickle cell anemia.
    Venketasubramanian N; Prohovnik I; Hurlet A; Mohr JP; Piomelli S
    Stroke; 1994 Nov; 25(11):2153-8. PubMed ID: 7974538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia.
    Bishop S; Matheus MG; Abboud MR; Cane ID; Adams RJ; Jackson SM; Kalpatthi R
    Blood Cells Mol Dis; 2011 Aug; 47(2):125-8. PubMed ID: 21724428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of automated erythrocytapheresis versus manual exchange transfusion to treat cerebral macrovasculopathy in sickle cell anemia.
    Koehl B; Sommet J; Holvoet L; Abdoul H; Boizeau P; Ithier G; Missud F; Couque N; Verlhac S; Voultoury P; Sellami F; Baruchel A; Benkerrou M
    Transfusion; 2016 May; 56(5):1121-8. PubMed ID: 27021622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.